China is interested in the IP, not GNBT/NGIO. Goodluck producing vaccine in China and collect royalties. Cant even confirm funds to develop vaccine . Im sure BARDA will have a few q's. Doesnt get better for China to have BARDA pay for development and hand final product to our Chinese partners .